Skip to main content
. 2016 Oct 9;8(3):5474–5486. doi: 10.18632/oncotarget.12547

Figure 3. Long-term survival curves of non-MVI (n = 180), low-MVI (n = 58) and high-MVI (n = 57) groups.

Figure 3

A., Comparison of overall survival rate: high-MVI vs non-MVI (P < 0.001); high-MVI vs low-MVI (P = 0.001); low-MVI vs non-MVI (P = 0.019). B., Comparison of recurrence-free survival rate: high-MVI vs non-MVI (P < 0.001); high-MVI vs low-MVI (P = 0.003); low-MVI vs non-MVI (P = 0.103).